Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
buy vibrator.
Popular Articles

PAREXEL Reaches Milestone In Management Of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, announced it has reached a milestone in managing oncology-based clinical trials over the last five years, which have involved over 175,000 patients in hundreds of programs across 80 countries. PAREXEL will be marking this milestone during the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 - June 2, 2009 in Orlando, Florida. PAREXEL"s hematology and oncology experts will be available during the ASCO meeting at Booth #1980 to discuss their capabilities to support the successful development of novel cancer treatments.
pharmacy online
BUPA Launches Breakthrough Treatment For Back And Knee Pain
New research reveals around 22 million people suffered back pain in the last year - just under half of all UK adults (45 percent)[1]. More than one in four UK adults - nearly 13 million people - suffered from knee pain in the last year. Over 80 percent of the people with back or knee pain still suffer some pain after undergoing treatment recommended by a healthcare professional. Bupa is making APOS Treatment for knee and lower back pain available in the UK for the first time. The breakthrough treatment can eliminate the need for prescription pain relief for seven out of 10 people[2].
News of the day
HIV/AIDS Groups Demonstrate At Capitol Rotunda, Call For Action On Domestic, Global Epidemics
Twenty-six people representing a coalition of five HIV/AIDS groups from Washington, D.C., Philadelphia and New York were arrested on Thursday for unlawfully demonstrating in the Capitol rotunda, the AP/Washington Post reports (7/9). According to Politico, the protestors were demanding "congressional action on three AIDS priorities: the end of the federal ban on syringe exchange, increased housing funding for [people living with AIDS] and significant increases in U.S. international AIDS contributions" (McGrane, 7/9). The group contends that the Obama "administration"s budget proposal "essentially flatlines global AIDS funding,"" CNN.com reports. In a statement, Omolola Adele-Oso of DC Fights Back, said, "HIV is not in recession. So why are we bailing out the bankers with $9 trillion, but breaking promises to fund life-saving AIDS programs in the U.S. and around the world at a fraction of that cost?" (7/9).
Public Health

Change In Measurement Of HBA1C For People With Diabetes, UK

From 1 June 2009, HbA1c (long term blood glucose levels) in all people with diabetes will be measured in millimoles per mol as well as by percentage, the Department of Health said today. The UK is responding to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) call for all countries to adopt the same measurement to make it easier to compare HbA1c results between laboratories throughout the UK and worldwide. Both the old and the new measurements will be given for the first two years of the change, until 31 May 2011 when people with diabetes will receive their HbA1c measurement only in millimoles per mol. Dr. Rowan Hillson MBE, National Clinical Director for Diabetes, said, "It is really important that people with diabetes keep their blood glucose levels under good control. Controlling the glucose in a way that is safe and appropriate for each person reduces the risk of diabetic tissue damage. People with diabetes need HbA1c blood tests to check their glucose is under good control. This necessary change in the way that HbA1c is reported is being introduced in a way that allows plenty of time for us all to get used to it." Simon O"Neill Director of Care and Policy at Diabetes UK said: "Diabetes UK welcomes this change to the way HbA1c results are reported and we believe that this will have the additional benefit of making comparing results from international laboratories and research trials easier, as the new system will be adopted worldwide. "For a period of 2 years people with diabetes will get their results in both percentage and millimoles per mol which will help them get used to the new system. In addition, Diabetes UK has designed a convenient online HbA1c converter tool for people with diabetes to help them through the transition. To use the calculator and for more general information on the changes and what they mean, people can visit http://www.diabetes.org.uk/HbA1c." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009